Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2054 participants.

Also called NCT02004509

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,054 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02004509
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02004509. Randomized; no masking; primary purpose treatment. Start 2015-02-06 (actual); primary completion 2025-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Acronym
SILENT
Intervention (Drug)
Anticoagulant
Lead sponsor
InCor Heart Institute (class: other)

Record details

Record id
cardio:ct-nct02004509
Content hash
1bc2ecbe86b3394c973e7e9d4bfaa0b0a7994922a530bd758fc8c3f7b52ba4fc